Art

J-GLOBAL ID：200902128294362175   Reference number：99A0069846

Antiplatelet Therapy in Cardiovascular Disease.

冠動脈疾患と抗血小板療法

Author (5)： MORISHITA ERIKO (金沢大 医) ,  ASAKURA HIDESAKU (金沢大 医) ,  JOKAJI HIROSHI (金沢大 医) ,  SAITO MASANORI (金沢大 医) ,  MATSUDA TAMOTSU (金沢大 医)
Material： 脈管学  (Journal of Japanese College of Angiology)
Volume： 38  Issue： 10  Page： 693-697  Publication year： Oct. 1998 
JST Material Number： Z0216B  ISSN： 0387-1126  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *Myocardial Ischemia ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=99A0069846&from=J-GLOBAL&jstjournalNo=Z0216B") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (3)： Warfarin ,  Aspirin ,  Ticlopidine

Reference (6)：

• Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I:Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet thrapy in various categories of patients. Brit.Med.J. 1994, 308, 81-106
• 定梶裕司. 脳血栓症の二次予防を目的とするチクロピジンの血小板凝集能を用いたモニタリングについての検討. 脳卒中. 1995, 17, 319-324
• The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N.Engl.J.Med. 1994, 330, 949-955
• Schoming, A. A randomized comparison of antiplatelet and anticoagulant therapy after placement of coronary-artery stents. N.Engl.J.Med. 1996, 334, 1084-1089
• Asakura, H. Prothrombin fragment 1+2 and thrombin-antithrombin III complex are usefull markers of the hypercoagulable state in arterial fibrillation. Blood Coagul.Fibrinolysis. 1992, 3, 469-473

Terms in the title (2)： 冠動脈疾患 ,  抗血小板療法